Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Health.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2018-12-14 SEM Ely James S. III (Director) A 1,088 82,920 1.33 16.55 18,006
2018-12-06 CIVI NARDELLA BRUCE F. (President and CEO, Director) F -5,965 568,725 -1.04 18.95 -113,037
2018-05-15 DVA THIRY KENT J (Co-Chairman & CEO, Director) G -144,128 392,078 -26.88
2018-02-15 KND WALLACE KENT (EVP & Chief Operating Officer) F -2,407 175,592 -1.35 9.00 -21,663
2018-02-15 KND Lucchese John Joseph (SVP & Chief Accounting Officer) F -661 52,209 -1.25 9.00 -5,949
2018-02-15 KND LANDENWICH JOSEPH L (General Counsel&Corp Secretary) F -2,235 156,758 -1.41 9.00 -20,115
2018-02-15 KND Kalmey Pete K (President, Hospital Division) F -2,013 99,421 -1.98 9.00 -18,117
2018-02-15 KND FARBER STEPHEN D (EVP & Chief Financial Officer) F -5,427 262,052 -2.03 9.00 -48,843
2018-02-15 KND Cunanan Stephen R (Chief Admin & People Officer) F -2,686 130,958 -2.01 9.00 -24,174
2018-02-15 KND Causby David A (EVP & Pres., Kindred at Home) F -3,625 320,971 -1.12 9.00 -32,625
2018-02-15 KND Breier Benjamin A (President & CEO, Director) F -18,298 1,084,276 -1.66 9.00 -164,682
2018-02-15 KND ALTMAN WILLIAM M (Executive VP for Strategy) F -2,743 149,202 -1.81 9.00 -24,687
2018-02-15 KND Zachariah Jason P. (President, KRS) F -1,202 74,919 -1.58 9.00 -10,818
2018-02-15 KND WALLACE KENT (EVP & Chief Operating Officer) A 9,000 177,999 5.33
2018-02-15 KND Lucchese John Joseph (SVP & Chief Accounting Officer) A 1,750 52,870 3.42
2018-02-15 KND LANDENWICH JOSEPH L (General Counsel&Corp Secretary) A 6,750 158,993 4.43
2018-02-15 KND Kalmey Pete K (President, Hospital Division) A 5,350 101,434 5.57
2018-02-15 KND FARBER STEPHEN D (EVP & Chief Financial Officer) A 16,200 267,479 6.45
2018-02-15 KND DIAZ PAUL J (Director) A 2,222 424,340 0.53
2018-02-15 KND Cunanan Stephen R (Chief Admin & People Officer) A 7,175 133,644 5.67
2018-02-15 KND Causby David A (EVP & Pres., Kindred at Home) A 11,700 324,596 3.74
2018-02-15 KND Breier Benjamin A (President & CEO, Director) A 58,341 1,102,574 5.59
2018-02-15 KND ALTMAN WILLIAM M (Executive VP for Strategy) A 7,350 151,945 5.08
2018-02-15 KND Zachariah Jason P. (President, KRS) A 3,237 76,121 4.44
2018-02-14 NHC HASSAN EMIL E (Director) M 4,865 60,509 8.74 47.45 230,844
2018-02-14 GHDX Popovits Kimberly J (President and CEO, Director) M 10,000 342,284 3.01 17.18 171,800
2018-02-14 CDNA Maag Peter (See Remarks, Director) M -89,938 239,037 -27.34 0.548 -49,286
2018-02-14 HCA Hall Charles J (Group President) M 119,637 161,181 287.98 22.6415 2,708,761
2018-02-14 SEM CRESSEY BRYAN C (Director) A 1,088 625,350 0.17 16.55 18,006
2018-02-14 SEM SWERGOLD LEOPOLD (Director) A 544 224,098 0.24 16.55 9,003
2018-02-14 SEM Frist William H. (Director) A 1,088 198,515 0.55 16.55 18,006
2018-02-14 HCA Hall Charles J (Group President) S -24,344 136,837 -15.10 99.9608 -2,433,446 13,678,336 -17.79
2018-02-14 GHDX Popovits Kimberly J (President and CEO, Director) S -10,000 332,284 -2.92 32.9336 -329,336 10,943,308 -3.01
2018-02-14 HCA Hall Charles J (Group President) S -95,293 41,544 -69.64 100.1917 -9,547,568 4,162,364 -229.38
2018-02-13 MGEN Marshall William Stuart (President & CEO, Director) M 115,818 265,646 77.30 0.57 66,016
2018-02-13 HCA CAMPBELL VICTOR L (SVP) M 5,664 339,516 1.70 5.9821 33,883
2018-02-13 HCA CAMPBELL VICTOR L (SVP) M 6,756 346,272 1.99 6.4772 43,760
2018-02-13 HCA CAMPBELL VICTOR L (SVP) M 2,252 348,524 0.65 10.9168 24,585
2018-02-13 HCA CAMPBELL VICTOR L (SVP) M 2,252 350,776 0.65 15.9112 35,832
2018-02-13 HCA CAMPBELL VICTOR L (SVP) M 75,000 425,776 21.38 22.95 1,721,250
2018-02-13 HCA CAMPBELL VICTOR L (SVP) F -44,535 381,241 -10.46 98.92 -4,405,402
2018-02-13 MGEN Booth Bruce (Director) P 545,454 4,493,670 13.82 5.50 2,999,997 24,715,185 12.14
2018-02-13 FMI Kafka Steven J. (President & COO) S -29,791 31,570 -48.55 61.55 -1,833,636 1,943,134 -94.36
2018-02-13 MGEN Levy Adam Scott (Chief Business Officer) P 9,090 10,540 626.90 5.50 49,995 57,970 86.24
2018-02-12 SGRY KRETSCHMER R. DAVID (CSTO; Interim CFO) A 34,364 34,364
2018-02-12 LH EISENBERG GLENN A (Chief Financial Officer, EVP) S -6,300 15,931 -28.34 167.157 -1,053,089 2,662,978 -39.55
2018-02-12 ENSG Nackel John G. (Director) S -3,000 96,232 -3.02 25.90 -77,700 2,492,409 -3.12
2018-02-12 LH EISENBERG GLENN A (Chief Financial Officer, EVP) S -1,600 14,331 -10.04 167.7775 -268,444 2,404,419 -11.16
2018-02-12 LH EISENBERG GLENN A (Chief Financial Officer, EVP) S -500 13,831 -3.49 168.614 -84,307 2,332,100 -3.62
2018-02-09 LH Ratliff John D (CEO, Covance Drug Development) M 6,100 11,650 109.91
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)